A-Z Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ALL
Icon: ADA  Font Size | A A A
Public Health Logo
Instagram Facebook Twitter Youtube
Acute Communicable Disease Control
Provider Info Hub (Vaccine) Health Facility COVID-19 Vaccine Checklist General Public Info (Vaccine)
Provider Information (Testing) Information for patients (Testing)
Reporting
Main Healthcare Facilities Page Skilled Nursing Facilities Community Care Facilities Outpatient Facilities (FAQ) Dedicated COVID-19 Patient Locations Transfer & Discharge Guidelines HCP Monitoring Guidelines
Provider Information (Isolation/Quarantine) Isolation Orders & Instructions for patients Quarantine Orders & Instructions for patients
LAHAN Alerts
Banner

COVID-19 Vaccine

Healthcare Provider Information Hub


Please refresh your browser to see the latest updates and versions of our documents.

New and Noteworthy - COVID-19 Vaccination

  • Advisory Committee on Immunization Practices (ACIP) Online Meeting. 2-24-23 5am-10:10am PT Draft agenda | Slides and live stream
  • Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting. 1-26-23 VRBPAC met to discuss future vaccination strategies for COVID-19. Recording | Slides
  • CDC & FDA Identify Preliminary COVID-19 Vaccine Safety Signal for Persons Aged 65 Years and Older. A joint statement was released by the CDC and FDA on 1-13-23 regarding the identification of a preliminary COVID-19 vaccine safety signal of increased stroke risk for persons 65 and older who received the Pfizer bivalent vaccine in one monitoring system, but not in any other systems. CDPH agrees with the recommendations in the federal statement that the updated bivalent vaccines are safe and effective against COVID-19. No change in vaccination practice is recommended given the totality of the evidence from the United States and other countries. See CDC & FDA statement | CDPH statement
  • Updated CDPH COVID-19 Vaccine job aids (12-12-22). CDPH has released updated vaccine timing guides and product guides. See COVID-19 Vaccine Timing Schedules and Product Guide.
  • CDC Expands Updated COVID-19 Vaccines to Include Children Ages 6 Months through 5 Years (12-9-22) Following FDA action, CDC expanded the use of updated (bivalent) COVID-19 vaccines for children ages 6 months through 5 years:
    • Moderna - Children ages 6 months through 5 years who previously completed a Moderna primary series are eligible to receive a Moderna bivalent booster 2 months after their final primary series dose.
    • Moderna - Children 5 years old who complete a Moderna primary series may receive either the previously authorized bivalent Pfizer booster dose or the newly authorized bivalent Moderna booster dose at least 2 months after completion of the Moderna primary series.
    • Pfizer – The 3rd dose of the primary series for children ages 6 months through 4 years has been replaced with a Pfizer bivalent vaccine. Children in this age group who have not yet received the 3rd dose of the primary series will receive a Pfizer bivalent vaccine as their 3rd dose at least 8 weeks after the 2nd monovalent primary series dose.
    • Pfizer - Children 5 years old who complete a Pfizer primary series are eligible to receive a Pfizer bivalent booster 2 months after their final primary series dose.
    • Pfizer - Children ages 6 months through 4 years who have completed a Pfizer primary series are NOT eligible for a bivalent booster dose at this time.

    LAC DPH patient-friendly vaccine schedules have been updated to reflect these changes and are available in multiple languages at ph.lacounty.gov/howtogetvaccinated

    See CDC announcement | CDC Clinical Considerations | CDC patient guidance Stay Up to Date with COVID-19 Vaccines Including Boosters (released Dec 22).

    A replay of the COCA call "COVID-19 Update: Clinical Guidance and Patient Education for Bivalent COVID-19" held on December 13, 2022, is available here.

Becoming a COVID-19 Vaccination Provider

DPH greatly appreciates the partnership of health care providers and organizations to administer the COVID-19 vaccine to their patient population and their surrounding community members.

It is now easier to enroll and provide COVID-19 vaccinations –

  • Ultralow freezers are not required
  • Vaccine can be ordered in small quantities
  • Providers never need to miss a vaccination opportunity because of fear of vaccine wastage – some vaccine wastage is to be expected
  • Grants are available for providers enrolled in the Vaccines for Children program
  • Extensive support is available for start-up and beyond. DPH can offer one on one assistance with the enrollment process.

View the flyer to learn more.

Detailed information regarding enrollment processes for joining the California COVID-19 Vaccination Program can be found at: https://eziz.org/covid/enrollment/.  The DPH Vaccination Partner Checklist has information and resources for providers offering COVID-19 vaccine.

Toolkit: Resources for Communicating with Parents & Children

This toolkit contains COVID-19 vaccine resources for patients (including fact sheets for parents and teens and activity sheets for children) along with provider resources (including sample letters) to support you when discussing and promoting COVID-19 vaccination to your patients.

Billing for Vaccinations Update

Providers cannot charge any out-of-pocket cost for COVID-19 vaccine. The vaccine must be made available at no cost to all individuals to ensure equitable access. Denying anyone vaccination or reducing appointments based on the person’s insurance status, charging for an office visit or other fee (if COVID-19 vaccination is the sole medical service provided), requiring additional medical services to receive COVID-19 vaccination, or seeking any additional reimbursement, including through balance billing from the vaccine recipient, is prohibited.

The loss of the HRSA COVID-19 Uninsured Program funding may prove a challenge to serving your neediest community members. Public Health is working hard to advocate with the federal and state government on your behalf. In the meantime, here are some considerations and resources to assist providers:

  • Providers may be able to bill Medicare, Medi-Cal or private insurance to obtain reimbursement for administering vaccines, and through other available mechanisms for the uninsured, where appropriate
  • California’s Department of Health Care Services will accept claims for individuals enrolled in the COVID-19 Uninsured Group Program. Individuals must apply for the COVID-19 Uninsured Group Program through a Medi-Cal Qualified Provider in the following programs: Presumptive Eligibility for Pregnant Women, Breast and Cervical Cancer Treatment Program, Hospital Presumptive Eligibility, and Child Health and Disability Prevention. Providers must submit applications via the COVID-19 Uninsured Group Application Portal.
  • Providers may refer any patient to a walk-in community vaccination site – they can visit the How to Get a Vaccine webpage or call the DPH Call Center at 833-540-0473 which is open 7 days a week from 8:00am-8:30pm for appointment or referral assistance
  • Providers may wish to hold onto records for possible future claim submission should the HRSA Uninsured Program receive funding and begin accepting claims, or another source of funding is established.
  • Billing and reimbursement webinar (4-29-22) from the California Department of Public Health and California Medical Association  Slides and recording.

Webinars and training series

See New and Noteworthy for new webinars

  • CDPH California COVID-19 Vaccination Program Consolidated webinar (COVID-19 vaccine, COVID-19 therapeutics, Monkeypox)– Updates and Q&A Fridays 9am-10:30am Registration, slides & recordings
  • CMA Virtual Grand Rounds with Paul Offit and Erica Pan –COVID-19 Vaccine Updates: Pediatric Vaccines and New Vaccine Technology. Recorded live 8-9-22. View on-demand webinar.
  • CDC Webinar Recommendations for the Novavax COVID-19 Primary Series in Adults Ages 18 and Older – FREE CME. Recorded live 7-28-22. View slides and recording.
  • CDC COVID-19 Vaccine Webinar Series (with CE) brief (15-20 minute) interactive modules that offer a real-world perspective on issues such as clinical and vaccine safety information, guidance for on-site clinic vaccination, and having conversations with vaccine recipients. Webinars
  • CDC Vaccine Training Modules (with CE) – new Janssen module. Modules include a general overview of immunization practices, and Janssen, Pfizer and Moderna vaccine storage, handling, preparation, administration, and documentation. Modules
  • CDC COCA Webinars: Clinician Outreach and Communication Activity (COCA) Past COVID-19 topics include underlying medical conditions and severe COVID-19, vaccine safety and efficacy, and treating long COVID. Recorded webinars | Subscribe.
  • CDC/IDSA COVID-19 Clinician Calls: Saturdays 12-1pm PT (see webpage for dates). Past webinars include post-COVID conditions, variants, vaccination, and COVID-19 outcomes in at-risk groups. Recorded webinars | Subscribe.
  • AMA COVID-19 webinar series - What Physicians Need to Know: Live and archived webinars on COVID-19 vaccine and therapeutics Webinars

Contact us about Vaccines

Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.

Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment

  • Monday through Friday, 8:00am-5:00pm, call 213-240-7941. For time-sensitive questions after hours, call 213-974-1234 and ask for the on-call clinician

CDC/CISAvax (Clinical Immunization Safety Assessment Project) - Consults about COVID-19 vaccine safety. Healthcare providers can request a consultation from CISA COVIDvax for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the United States or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices (ACIP) guidelines. CISA has vaccine safety subject matter experts in multiple specialties (e.g. ID, allergy/immunology, neurology, OB/GYN, pediatrics, geriatrics)

  • Contact CDC_INFO: 800-CDC-INFO (800-232-4636) or online
  • In case of an emergent clinical COVID-19 vaccine safety inquiry, healthcare providers can call the CDC Emergency Operations Center (EOC) Watch Desk at (770)-488-7100. The EOC Watch Desk will route emergency inquiries to the CISA COVIDvax on-call staff.

Medical professionals interested in supporting the COVID-19 response:


Icon: Get Adobe Reader
Adobe Reader

Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.



Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.

Los Angeles County Seal: Enriching lives through effective and caring services